Alpha-interferon-2b treatment for chronic hepatitis-B infection in children with cancer

Journal of Tropical Pediatrics

Volumn 42, Issue 5, 1996, Pages 262-266

  Çetingül, Nazan ^a   Kavakli, Kaan ^a   Vergin, Canan ^a   Öztop, Senay ^a   Nişli, Güngör ^a   Aydoǧdu, Sema ^a   Özacar, Tijen ^a   Bilgiç, Altinay ^a   Yüce, Gül ^a   Yaǧci, Raşt ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; RECOMBINANT ALPHA2B INTERFERON; VIRUS DNA;

ADOLESCENT; ARTICLE; CHILD; CHRONIC ACTIVE HEPATITIS; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LYMPHATIC LEUKEMIA; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SEROCONVERSION; SOLID TUMOR; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 10244229684     PISSN: 01426338     EISSN: None     Source Type: Journal    
DOI: 10.1093/tropej/42.5.262     Document Type: Article

References (18)

1. Pirnar A, Kanra T. Incidence and distribution of hepatitis-Bs antigen in Turkey. Vox Sang 1976; 31: 67-9.
2. Özsoylu S. Transfusion and hepatitis B infection in developing countries. Pediatr Hematol Oncol 1994; 11: 119-20.
3. Maddrey WC. Chronic Hepatitis B. In: Bone RC (ed.) In Disease - a month. St Louis: Mosby Year Book Inc, 1993; 74-90.
4. Wands JR, Chura CM, Roll FJ, Maddrey WC. Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. Gastroenterology 1975; 68: 105-12.
5. Editorial. Chemotherapy and Hepatitis B. Lancet 1989; i: 1136-7.
6. Bonino F (ed.). Chronic hepatitis B. The role of interferons in chronic viral hepatitis. Macclesfield Gardiner-Caldwell Co, 1992; 10-36.
7. Hadziyannis SJ, Schiff ER (eds). Clinical experience with alpha intereferon in hepatitis B. In: The management of chronic hepatitis B. Macclesfield: Adelphi com., UK, 1992; 12-16.
8. La Banda F, et al. Recombinant alpha-2b interferon treatment in children with chronic hepatitis B. Lancet 1988; i: 250.
9. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1991; 13: 431-5.
10. Lieberman HM, et al. Detection of Hepatitis B viras DNA directly in human serum by a simplified moleculer hybridization test. Hepatology 1983; 3: 285-91.
11. Wright TL. Chronic hepatitis B and C. What is the status of drug therapy. Postgrad Med 1992; 92: 75-82.
12. Perrillo RP, et al. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial. Ann Int Med 1988; 109: 95-100.
13. Eddleston ALWF (ed.). Practical guidelines: alpha interferon in the treatment of patients with Chronic Hepatitis B. Bollington Adelphi communications, 1991; 6-36.
14. Peters M. Alpha-interferon combined with immunomodulation in the treatment of chronic hepatititis B. J Gastroenterol Hepatol 1991; 6: Suppl. 1, p. 13-14.
15. Peters M, Wierling J, Gershwin E, Milich D, Chisan FV, Hoofnagle JH. Immunology and the liver. Hepatology 1991; 13: 977-94.
16. Paul RG, Roodman ST, Campbell CR, Bodicky CJ, Perrillo P. HLA class I antigen expression as a measure of response to antiviral therapy of chronic hepatitis B. Hepatology 1991; 13: 820-5.
17. Utuli R, et al. Prolonged treatment of children with chronic hepatitis B with recombinant α 2a-interferon: a controlled, randomized study. Am J Gastroenterol 1991; 86: 327-30.
18. Özen H. Is interferon treatment required in chronic hepatitis B infection? Turk J Med Sci 1993; 17: 81-2.